RIL’s letter to Stock Exchange related to its Investment in Strand Life Sciences Private Limited
Chennaivision
4 Sep 2021
Share this:
RIL intimation to Stock Exchanges: Update on investment in Reliance Infratel Limited.
Date
December 23, 2022
In relation to
Business News
Strand Life Sciences, a Reliance subsidiary, Launches Pioneering Blood-based Test for Early Detection of Multiple Cancers
Date
December 4, 2024
In relation to
Business News
Reliance Industries Doubling PET recycling capacity
Date
August 5, 2021
In relation to
Business News
Exit mobile version
